Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatocytes | 3 | 2008 | 85 | 0.340 |
Why?
|
| Inclusion Bodies | 2 | 2008 | 20 | 0.340 |
Why?
|
| Biomarkers | 1 | 2007 | 214 | 0.250 |
Why?
|
| Epigenesis, Genetic | 2 | 2008 | 36 | 0.130 |
Why?
|
| Liver | 2 | 2008 | 157 | 0.130 |
Why?
|
| Amnion | 2 | 2007 | 15 | 0.130 |
Why?
|
| Cyclic AMP | 2 | 2007 | 30 | 0.130 |
Why?
|
| Amniotic Fluid | 3 | 2006 | 44 | 0.130 |
Why?
|
| Placenta | 3 | 2006 | 58 | 0.120 |
Why?
|
| Lipopolysaccharides | 2 | 2006 | 41 | 0.110 |
Why?
|
| Cytokines | 2 | 2006 | 80 | 0.110 |
Why?
|
| S-Adenosylmethionine | 2 | 2008 | 17 | 0.090 |
Why?
|
| Proteins | 2 | 2008 | 41 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2008 | 88 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2007 | 34 | 0.080 |
Why?
|
| RNA, Messenger | 5 | 2008 | 190 | 0.070 |
Why?
|
| Ubiquitins | 1 | 2008 | 14 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 2008 | 12 | 0.070 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2008 | 11 | 0.070 |
Why?
|
| Keratin-18 | 1 | 2007 | 2 | 0.070 |
Why?
|
| Biopsy | 1 | 2007 | 36 | 0.070 |
Why?
|
| Animals | 6 | 2008 | 1875 | 0.070 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2007 | 29 | 0.070 |
Why?
|
| Second Messenger Systems | 1 | 2007 | 6 | 0.070 |
Why?
|
| Aquaporins | 1 | 2007 | 11 | 0.060 |
Why?
|
| Fatty Liver | 1 | 2007 | 59 | 0.060 |
Why?
|
| Pregnancy | 5 | 2007 | 599 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2008 | 90 | 0.060 |
Why?
|
| Aquaporin 3 | 1 | 2006 | 3 | 0.060 |
Why?
|
| Acetylcysteine | 1 | 2006 | 9 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2006 | 30 | 0.060 |
Why?
|
| Antioxidants | 1 | 2006 | 37 | 0.060 |
Why?
|
| Pregnancy, Animal | 1 | 2005 | 15 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2005 | 48 | 0.060 |
Why?
|
| Rats | 4 | 2008 | 571 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2004 | 7 | 0.050 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2004 | 21 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2008 | 29 | 0.050 |
Why?
|
| Mice, Inbred C3H | 3 | 2008 | 39 | 0.050 |
Why?
|
| Up-Regulation | 3 | 2008 | 94 | 0.050 |
Why?
|
| Mice | 3 | 2008 | 746 | 0.040 |
Why?
|
| Humans | 3 | 2007 | 6794 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2006 | 282 | 0.040 |
Why?
|
| Female | 5 | 2007 | 4060 | 0.040 |
Why?
|
| Carcinogens | 2 | 2008 | 11 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2008 | 231 | 0.030 |
Why?
|
| Cell Culture Techniques | 2 | 2007 | 18 | 0.030 |
Why?
|
| Male | 3 | 2008 | 3671 | 0.030 |
Why?
|
| Zalcitabine | 1 | 2008 | 2 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2008 | 6 | 0.020 |
Why?
|
| Aldehydes | 1 | 2008 | 8 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2008 | 2 | 0.020 |
Why?
|
| Drug Antagonism | 1 | 2008 | 2 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2008 | 5 | 0.020 |
Why?
|
| Methylation | 1 | 2008 | 9 | 0.020 |
Why?
|
| Dihydropyridines | 1 | 2008 | 11 | 0.020 |
Why?
|
| Acetylation | 1 | 2008 | 10 | 0.020 |
Why?
|
| Histones | 1 | 2008 | 13 | 0.020 |
Why?
|
| RNA | 1 | 2008 | 25 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2008 | 20 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2008 | 38 | 0.020 |
Why?
|
| Colforsin | 1 | 2007 | 7 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 234 | 0.020 |
Why?
|
| Gene Expression | 1 | 2007 | 77 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2007 | 49 | 0.020 |
Why?
|
| Homeostasis | 1 | 2006 | 40 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 118 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2006 | 10 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2006 | 45 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 2005 | 6 | 0.010 |
Why?
|
| Extraembryonic Membranes | 1 | 2005 | 6 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 43 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2005 | 20 | 0.010 |
Why?
|
| Inflammation | 1 | 2005 | 143 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 35 | 0.010 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2004 | 21 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2004 | 19 | 0.010 |
Why?
|
| Brain | 1 | 2004 | 94 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 767 | 0.010 |
Why?
|
| Adult | 1 | 2007 | 2113 | 0.010 |
Why?
|